1. Home
  2. NOTV vs MXE Comparison

NOTV vs MXE Comparison

Compare NOTV & MXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • MXE
  • Stock Information
  • Founded
  • NOTV 1974
  • MXE 1990
  • Country
  • NOTV United States
  • MXE United States
  • Employees
  • NOTV N/A
  • MXE N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • MXE Finance Companies
  • Sector
  • NOTV Health Care
  • MXE Finance
  • Exchange
  • NOTV Nasdaq
  • MXE Nasdaq
  • Market Cap
  • NOTV 46.7M
  • MXE 52.2M
  • IPO Year
  • NOTV 1997
  • MXE N/A
  • Fundamental
  • Price
  • NOTV $1.39
  • MXE $11.54
  • Analyst Decision
  • NOTV Strong Buy
  • MXE
  • Analyst Count
  • NOTV 1
  • MXE 0
  • Target Price
  • NOTV $5.00
  • MXE N/A
  • AVG Volume (30 Days)
  • NOTV 446.2K
  • MXE 5.8K
  • Earning Date
  • NOTV 08-06-2025
  • MXE 01-01-0001
  • Dividend Yield
  • NOTV N/A
  • MXE 2.66%
  • EPS Growth
  • NOTV N/A
  • MXE N/A
  • EPS
  • NOTV N/A
  • MXE N/A
  • Revenue
  • NOTV $505,299,000.00
  • MXE N/A
  • Revenue This Year
  • NOTV $5.64
  • MXE N/A
  • Revenue Next Year
  • NOTV $5.16
  • MXE N/A
  • P/E Ratio
  • NOTV N/A
  • MXE N/A
  • Revenue Growth
  • NOTV 0.85
  • MXE N/A
  • 52 Week Low
  • NOTV $1.15
  • MXE $8.40
  • 52 Week High
  • NOTV $6.48
  • MXE $11.51
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 42.19
  • MXE 50.45
  • Support Level
  • NOTV $1.41
  • MXE $11.48
  • Resistance Level
  • NOTV $1.57
  • MXE $11.92
  • Average True Range (ATR)
  • NOTV 0.12
  • MXE 0.23
  • MACD
  • NOTV 0.02
  • MXE -0.07
  • Stochastic Oscillator
  • NOTV 31.19
  • MXE 27.27

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About MXE Mexico Equity and Income Fund Inc. (The)

Mexico Equity and Income Fund Inc is a closed-end, non-diversified management investment company. It maintains an investment objective of long-term capital appreciation through investments in securities, primarily equity, listed on the Mexican Stock Exchange. The company provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.

Share on Social Networks: